BIRB 796 (Doramapimod) is a highly selective p38α MAPK inhibitor with Kd of 0.1 nM, 330-fold greater selectivity versus JNK2, weak inhibition for c-RAF, Fyn and Lck, insignificant inhibition of ERK-1, SYK, IKK2, ZAP-70, EGFR, HER2, PKA, PKC, PKCα/β/γ.
Chemical Name: 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea
Biological Activity: |
Biological Activity |
BIRB 796 (Doramapimod) is a highly selective p38α MAPK inhibitor with Kd of 0.1 nM, 330-fold greater selectivity versus JNK2, weak inhibition for c-RAF, Fyn and Lck, insignificant inhibition of ERK-1, SYK, IKK2, ZAP-70, EGFR, HER2, PKA, PKC, PKCα/β/γ. |
Technical Data: |
M.W. |
527.66 |
Formula: |
C<sub>31</sub>H<sub>37</sub>N<sub>5</sub>O<sub>3</sub> |
Solubility: |
DMSO |
Purity: |
98% |
Storage: |
-20℃ |
CAS No: |
285983-48-4 |
References: |
References |
Pargellis C, et al. Nat Struct Biol, 2002, 9(4), 268-272.
Regan J, et al. J Med Chem, 2002, 45(14), 2994-3008.
Kuma Y, et al. J Biol Chem, 2005, 280(20), 19472-19479.
Yasui H, et al. Br J Haematol, 2007, 136(3), 414-423.
Dietrich J, et al. Bioorg Med Chem. 2010, 18(15), 5738-5748.
Regan J, et al. J Med Chem, 2003, 46(22), 4676-4686. |